AI is revolutionizing biotech startups, particularly in drug discovery and protein engineering. Companies like Genesis Therapeutics and Adaptyv Bio use AI to streamline drug development, reduce costs, and create personalized treatments. Despite challenges like high implementation costs and data requirements, substantial investments highlight the promising future of AI-driven biotech innovations.